Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals, Inc.

Biotechnology • Healthcare • Los Angeles, CA, United States • ARMP (ASE)

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc.

310 665 2928 5005 McConnell Avenue, Los Angeles, CA 90066, United States

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Armata Pharmaceuticals Announces Third Quarter 2025 Results and Provides Corporate Update - PR Newswire
PR Newswire • Nov 12
Armata Pharmaceuticals (ARMP) Surges 103.2%: Is This an Indication of Further Gains? - Yahoo Finance
Yahoo Finance • Oct 23
Will Armata Pharmaceuticals Inc stock maintain dividend yield - Market Risk Summary & Growth Focused Entry Reports - moha.gov.vn
moha.gov.vn • Dec 28
Armata Pharmaceuticals Stock Soars To Record High After Phage Therapy Data In Deadly Infection Trial; Retail Traders Pile In - Stocktwits
Stocktwits • Oct 22
Here’s Why Armata Pharmaceuticals Stock (ARMP) Exploded 300% Today - TipRanks
TipRanks • Oct 22

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has Armata Pharmaceuticals, Inc. had layoffs?
No layoff events have been recorded for Armata Pharmaceuticals, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Armata Pharmaceuticals, Inc. have?
Armata Pharmaceuticals, Inc. has approximately 60 employees.
What industry is Armata Pharmaceuticals, Inc. in?
Armata Pharmaceuticals, Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is Armata Pharmaceuticals, Inc. a publicly traded company?
Yes, Armata Pharmaceuticals, Inc. is publicly traded under the ticker symbol ARMP on the ASE. The company has a market capitalization of approximately $0.24 billion.
Where is Armata Pharmaceuticals, Inc. headquartered?
Armata Pharmaceuticals, Inc. is headquartered in Los Angeles, CA, United States at 5005 McConnell Avenue, Los Angeles, CA 90066, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.